A 3D-rendered digital illustration of a molecular structure floating among red blood cells in a bloodstream environment.
Explainers

Explained: How are metabolite biomarkers improving drug discovery and development?

By offering a rich source of insights into disease and drugs, metabolite biomarkers are at the forefront of therapeutic exploration.

Metabolites provide a real-time snapshot of the body’s biochemical activity, revealing how diseases take hold, how drugs interact with the body, and why some treatments work better than others. With over 220,000 distinct metabolites identified in the human body, their role in drug discovery and development is becoming increasingly critical.  

Download this Explainer Article to learn how metabolite biomarkers are helping scientists uncover disease mechanisms, identify drug targets, and improve drug safety and efficacy.

Supported by

  • Takara

Top Image Credit: